XJPX
4427
Market cap19mUSD
Dec 05, Last price
294.00JPY
1D
0.68%
1Q
-17.65%
IPO
-93.36%
Name
EduLab Inc
Chart & Performance
P/E
—
P/S
0.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.80%
Rev. gr., 5y
2.63%
Revenues
7.14b
+1.14%
Net income
-1.27b
L-58.99%
CFO
-1.23b
L
Dividend
Sep 29, 202030 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EduLab, Inc., together with its subsidiaries, researches and develops academic ability measurement technologies and educational tools in Japan and internationally. The company provides test and learning services primarily for languages educational institutions, including universities, private companies, and individuals. It also offers Einavi! and StudyGear, an online service that supports learners preparing for the test in practical English proficiency; Eiken Jr., a testing and game based English learning program for preschool through junior high-school; TEAP CBT; an English proficiency test for reading, writing, listening, and speaking; computerized assessment system for English communication (CASEC), an English proficiency test that utilizes item response theory and computer-adaptive testing technologies; speaking test systems for Eiken grade 4 and 5; and support systems for Eiken group enrollment. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||